Clinical Trial Update: Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of tipifarnib, temozolomide, and radiation therapy in newly diagnosed glioblastoma multiforme or gliosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Status: COMPLETED